A tumor-suppressing role for SYK has been demonstrated in e.g. breast cancer [26], pancreatic cancer [27], melanoma [28], hepatocellular carcinoma [29] as well as childhood pro-B-ALL [30]. This evidence concerns the gene SYK and neoplasm.